SlideShare a Scribd company logo
1 of 1
Download to read offline
STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES:
Platelet glycoprotein VI and SARS-CoV-2 receptor binding domain
Platelet glycoprotein VI (GPVI) is a potential target for the development of new
antiplatelet molecules with low bleeding risk. GPVI binding to vascular collagen initiates
thrombus formation and GPVI interactions with fibrin stimulate the growth and stability
of the thrombus.
The study demonstrates that Glenzocimab inhibits GPVI interactions with both ligands
by loss of dimerization, conformational changes, and steric hindrance.
• The crystal structure of Glenzocimab with the monomeric extracellular domain of
GPVI was determined to 1.9 Å.
• The crystal structure shows that Glenzocimab binds to the site of dimerization in the
D2 domain of GPVI.
• Glenzocimab inhibits GPIV interaction with CRP, collagen and fibrin by loss of
dimerization, conformational changes and steric hindrance.
AUTHORS: NADIA ROSE, DOROTA FOCHT, MARTIN WELIN AND RAYMOND KIMBUNG
Nadia Rose, Line Manager
nadia.rose@saromics.com
Contact
Platelet glycoprotein VI
SARS-CoV-2 receptor binding domain
The SARS-CoV-2 pandemic has been a major public health issue
worldwide. Although the population has widely received vaccination
against SARS-CoV-2, immunocompromised patients can still be
susceptible to infection.
The study demonstrates how two different hmAbs (1D1 and 3D2)
that showed high binding activity to the RBD of SARS-CoV-2 could
be used against multiple variants of the virus and provide
therapeutic benefits to COVID-19 patients.
• We determined the structures of
• 1D1 Fab – RBD complex to 1.9 Å
• 3D2 Fab – RBD (beta variant) complex to 2.2 Å
• Pseudovirion-based neutralization results showed that the
antibody cocktail of 1D1 and 3D2 showed high potency in
multiple variants of SARS-CoV-2 infection.
• The results illustrate the potential of this cocktail as an
intervention against SARS-CoV-2 infection.
• In vivo studies showed the ability of the antibody cocktail
treatment to reduce viral load (beta variant) in blood and various
tissues.
Reference: Boonkrai C, Cotrone TS, Chaisuriyong W, Tantawichien T, Thisyakorn U, Fernandez S, Hunsawong T, Reed M,
Wongtangprasert T, Audomsun T, Phakham T, Attakitbancha C, Saelao P, Focht D, Kimbung R, Welin M, Malik AA, Pisitkun T,
Srisawat N. PLoS One 2023 May 4;18(5):e0284173.
Reference: Billiald P, Slater A, Welin M, Clark JC, Loyau S, Pugnière M, Jiacomini IG, Rose N, Lebozec K, Toledano E, François
D, Watson SP, Jandrot-Perrus M. Blood Adv. 2023 Apr 11;7(7):1258-1268.
D1
D2
LC
HC
D1
D2
A) Dimerization of GPVI (PDB ID 2GI7) colored in green and magenta. B) Superimposition of
monomeric GPVI domain D2 (yellow) revealing conformational changes that disrupt the dimerization.
Same color scheme as in A.
GPVI –D2
GPVI –D2 GPVI –D2
When Glenzocimab binds to domain D2 of GPVI, there is a rearrangement in a loop
region. This loop changes conformation and part of the loop forms a β-strand that
extends the β-sheet. The extended β-sheet disrupts the formation of a dimer.
A B
A B
A) Complex of Glenzocimab – GPVI. B) Superimpostion of one molecule of dimeric GPVI (PDB ID 2GI7) with GPVI from
the Glenzocimab – GPVI complex.
Mode of action

More Related Content

Similar to STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES: Platelet glycoprotein VI and SARS-CoV-2 receptor binding domain

FoulkesLi2015-PMS2_founder_mismatch_repair
FoulkesLi2015-PMS2_founder_mismatch_repairFoulkesLi2015-PMS2_founder_mismatch_repair
FoulkesLi2015-PMS2_founder_mismatch_repair
Kristi Baker
 
Preprint book rbd targeted covid vaccine and full length spike protein vacc...
Preprint  book  rbd targeted covid vaccine and full length spike protein vacc...Preprint  book  rbd targeted covid vaccine and full length spike protein vacc...
Preprint book rbd targeted covid vaccine and full length spike protein vacc...
M. Luisetto Pharm.D.Spec. Pharmacology
 

Similar to STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES: Platelet glycoprotein VI and SARS-CoV-2 receptor binding domain (20)

atypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptxatypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptx
 
anti vegf.pptx
anti vegf.pptxanti vegf.pptx
anti vegf.pptx
 
blood
bloodblood
blood
 
FoulkesLi2015-PMS2_founder_mismatch_repair
FoulkesLi2015-PMS2_founder_mismatch_repairFoulkesLi2015-PMS2_founder_mismatch_repair
FoulkesLi2015-PMS2_founder_mismatch_repair
 
Preprint book rbd targeted covid vaccine and full length spike protein vacc...
Preprint  book  rbd targeted covid vaccine and full length spike protein vacc...Preprint  book  rbd targeted covid vaccine and full length spike protein vacc...
Preprint book rbd targeted covid vaccine and full length spike protein vacc...
 
The Pathogenesis of Rheumatoid Arthritis.pptx
The Pathogenesis of Rheumatoid Arthritis.pptxThe Pathogenesis of Rheumatoid Arthritis.pptx
The Pathogenesis of Rheumatoid Arthritis.pptx
 
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdfALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
 
Thesis_Ladan_Mansouri
Thesis_Ladan_MansouriThesis_Ladan_Mansouri
Thesis_Ladan_Mansouri
 
Osmf rnk
Osmf rnkOsmf rnk
Osmf rnk
 
Bank1
Bank1Bank1
Bank1
 
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
 
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
 
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
 
cao2008.pdf
cao2008.pdfcao2008.pdf
cao2008.pdf
 
Identification of the Enrichment Pathways of Catalase in Multiple Primary Tumors
Identification of the Enrichment Pathways of Catalase in Multiple Primary TumorsIdentification of the Enrichment Pathways of Catalase in Multiple Primary Tumors
Identification of the Enrichment Pathways of Catalase in Multiple Primary Tumors
 
BF
BFBF
BF
 
Graft versus-host disease
Graft versus-host diseaseGraft versus-host disease
Graft versus-host disease
 
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson PublishersProteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
 
Overview of platelet physiology
Overview of platelet physiologyOverview of platelet physiology
Overview of platelet physiology
 
Periodontal medicine.pptx
Periodontal medicine.pptxPeriodontal medicine.pptx
Periodontal medicine.pptx
 

Recently uploaded

Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
David Celestin
 
Unlocking Exploration: Self-Motivated Agents Thrive on Memory-Driven Curiosity
Unlocking Exploration: Self-Motivated Agents Thrive on Memory-Driven CuriosityUnlocking Exploration: Self-Motivated Agents Thrive on Memory-Driven Curiosity
Unlocking Exploration: Self-Motivated Agents Thrive on Memory-Driven Curiosity
Hung Le
 

Recently uploaded (20)

Introduction to Artificial intelligence.
Introduction to Artificial intelligence.Introduction to Artificial intelligence.
Introduction to Artificial intelligence.
 
LITTLE ABOUT LESOTHO FROM THE TIME MOSHOESHOE THE FIRST WAS BORN
LITTLE ABOUT LESOTHO FROM THE TIME MOSHOESHOE THE FIRST WAS BORNLITTLE ABOUT LESOTHO FROM THE TIME MOSHOESHOE THE FIRST WAS BORN
LITTLE ABOUT LESOTHO FROM THE TIME MOSHOESHOE THE FIRST WAS BORN
 
2024-05-15-Surat Meetup-Hyperautomation.pptx
2024-05-15-Surat Meetup-Hyperautomation.pptx2024-05-15-Surat Meetup-Hyperautomation.pptx
2024-05-15-Surat Meetup-Hyperautomation.pptx
 
History of Morena Moshoeshoe birth death
History of Morena Moshoeshoe birth deathHistory of Morena Moshoeshoe birth death
History of Morena Moshoeshoe birth death
 
globalisation project report displayed overview
globalisation project report displayed overviewglobalisation project report displayed overview
globalisation project report displayed overview
 
SaaStr Workshop Wednesday with CEO of Guru
SaaStr Workshop Wednesday with CEO of GuruSaaStr Workshop Wednesday with CEO of Guru
SaaStr Workshop Wednesday with CEO of Guru
 
Molecular docking- Laxman I. Nimbale.pptx
Molecular docking- Laxman  I. Nimbale.pptxMolecular docking- Laxman  I. Nimbale.pptx
Molecular docking- Laxman I. Nimbale.pptx
 
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
Proofreading- Basics to Artificial Intelligence Integration - Presentation:Sl...
 
SaaStr Workshop Wednesdays - RevenueCat.pdf
SaaStr Workshop Wednesdays - RevenueCat.pdfSaaStr Workshop Wednesdays - RevenueCat.pdf
SaaStr Workshop Wednesdays - RevenueCat.pdf
 
The Concession of Asaba International Airport: Balancing Politics and Policy ...
The Concession of Asaba International Airport: Balancing Politics and Policy ...The Concession of Asaba International Airport: Balancing Politics and Policy ...
The Concession of Asaba International Airport: Balancing Politics and Policy ...
 
BIG DEVELOPMENTS IN LESOTHO(DAMS & MINES
BIG DEVELOPMENTS IN LESOTHO(DAMS & MINESBIG DEVELOPMENTS IN LESOTHO(DAMS & MINES
BIG DEVELOPMENTS IN LESOTHO(DAMS & MINES
 
BEAUTIFUL PLACES TO VISIT IN LESOTHO.pptx
BEAUTIFUL PLACES TO VISIT IN LESOTHO.pptxBEAUTIFUL PLACES TO VISIT IN LESOTHO.pptx
BEAUTIFUL PLACES TO VISIT IN LESOTHO.pptx
 
STM valmiusseminaari 26-04-2024 PUUMALAINEN Ajankohtaista kansainvälisestä yh...
STM valmiusseminaari 26-04-2024 PUUMALAINEN Ajankohtaista kansainvälisestä yh...STM valmiusseminaari 26-04-2024 PUUMALAINEN Ajankohtaista kansainvälisestä yh...
STM valmiusseminaari 26-04-2024 PUUMALAINEN Ajankohtaista kansainvälisestä yh...
 
Using AI to boost productivity for developers
Using AI to boost productivity for developersUsing AI to boost productivity for developers
Using AI to boost productivity for developers
 
Unlocking Exploration: Self-Motivated Agents Thrive on Memory-Driven Curiosity
Unlocking Exploration: Self-Motivated Agents Thrive on Memory-Driven CuriosityUnlocking Exploration: Self-Motivated Agents Thrive on Memory-Driven Curiosity
Unlocking Exploration: Self-Motivated Agents Thrive on Memory-Driven Curiosity
 
ECOLOGY OF FISHES.pptx full presentation
ECOLOGY OF FISHES.pptx full presentationECOLOGY OF FISHES.pptx full presentation
ECOLOGY OF FISHES.pptx full presentation
 
2024 mega trends for the digital workplace - FINAL.pdf
2024 mega trends for the digital workplace - FINAL.pdf2024 mega trends for the digital workplace - FINAL.pdf
2024 mega trends for the digital workplace - FINAL.pdf
 
in kuwait௹+918133066128....) @abortion pills for sale in Kuwait City
in kuwait௹+918133066128....) @abortion pills for sale in Kuwait Cityin kuwait௹+918133066128....) @abortion pills for sale in Kuwait City
in kuwait௹+918133066128....) @abortion pills for sale in Kuwait City
 
SOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdf
SOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdfSOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdf
SOLID WASTE MANAGEMENT SYSTEM OF FENI PAURASHAVA, BANGLADESH.pdf
 
Digital collaboration with Microsoft 365 as extension of Drupal
Digital collaboration with Microsoft 365 as extension of DrupalDigital collaboration with Microsoft 365 as extension of Drupal
Digital collaboration with Microsoft 365 as extension of Drupal
 

STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES: Platelet glycoprotein VI and SARS-CoV-2 receptor binding domain

  • 1. STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES: Platelet glycoprotein VI and SARS-CoV-2 receptor binding domain Platelet glycoprotein VI (GPVI) is a potential target for the development of new antiplatelet molecules with low bleeding risk. GPVI binding to vascular collagen initiates thrombus formation and GPVI interactions with fibrin stimulate the growth and stability of the thrombus. The study demonstrates that Glenzocimab inhibits GPVI interactions with both ligands by loss of dimerization, conformational changes, and steric hindrance. • The crystal structure of Glenzocimab with the monomeric extracellular domain of GPVI was determined to 1.9 Å. • The crystal structure shows that Glenzocimab binds to the site of dimerization in the D2 domain of GPVI. • Glenzocimab inhibits GPIV interaction with CRP, collagen and fibrin by loss of dimerization, conformational changes and steric hindrance. AUTHORS: NADIA ROSE, DOROTA FOCHT, MARTIN WELIN AND RAYMOND KIMBUNG Nadia Rose, Line Manager nadia.rose@saromics.com Contact Platelet glycoprotein VI SARS-CoV-2 receptor binding domain The SARS-CoV-2 pandemic has been a major public health issue worldwide. Although the population has widely received vaccination against SARS-CoV-2, immunocompromised patients can still be susceptible to infection. The study demonstrates how two different hmAbs (1D1 and 3D2) that showed high binding activity to the RBD of SARS-CoV-2 could be used against multiple variants of the virus and provide therapeutic benefits to COVID-19 patients. • We determined the structures of • 1D1 Fab – RBD complex to 1.9 Å • 3D2 Fab – RBD (beta variant) complex to 2.2 Å • Pseudovirion-based neutralization results showed that the antibody cocktail of 1D1 and 3D2 showed high potency in multiple variants of SARS-CoV-2 infection. • The results illustrate the potential of this cocktail as an intervention against SARS-CoV-2 infection. • In vivo studies showed the ability of the antibody cocktail treatment to reduce viral load (beta variant) in blood and various tissues. Reference: Boonkrai C, Cotrone TS, Chaisuriyong W, Tantawichien T, Thisyakorn U, Fernandez S, Hunsawong T, Reed M, Wongtangprasert T, Audomsun T, Phakham T, Attakitbancha C, Saelao P, Focht D, Kimbung R, Welin M, Malik AA, Pisitkun T, Srisawat N. PLoS One 2023 May 4;18(5):e0284173. Reference: Billiald P, Slater A, Welin M, Clark JC, Loyau S, Pugnière M, Jiacomini IG, Rose N, Lebozec K, Toledano E, François D, Watson SP, Jandrot-Perrus M. Blood Adv. 2023 Apr 11;7(7):1258-1268. D1 D2 LC HC D1 D2 A) Dimerization of GPVI (PDB ID 2GI7) colored in green and magenta. B) Superimposition of monomeric GPVI domain D2 (yellow) revealing conformational changes that disrupt the dimerization. Same color scheme as in A. GPVI –D2 GPVI –D2 GPVI –D2 When Glenzocimab binds to domain D2 of GPVI, there is a rearrangement in a loop region. This loop changes conformation and part of the loop forms a β-strand that extends the β-sheet. The extended β-sheet disrupts the formation of a dimer. A B A B A) Complex of Glenzocimab – GPVI. B) Superimpostion of one molecule of dimeric GPVI (PDB ID 2GI7) with GPVI from the Glenzocimab – GPVI complex. Mode of action